moderately emetogenic chemotherapycolorectal cancerXELOXCetuximabIrinotecanOncohaematology Pharmaceutical Care ClinicBevacizumabpalonosetronnetupitant
…iemetic optimisation in colorectal cancer patients treated with moderately emetogenic chemotherapy enabled substantial regimen reduction while maintaining high ra…